Subclassifications Of Assets, Liabilities And Equities [Abstract]

Innate Pharma - Filing #882171

Concept	As at 2021-12-31	As at 2020-12-31	As at 2019-12-31
Subclassifications of assets, liabilities and equities [abstract]
Property, plant and equipment [abstract]
Property, plant and equipment	10 174 EUR	11 694 EUR	—
Intangible assets and goodwill [abstract]
Intangible assets other than goodwill [abstract]
Intangible assets other than goodwill	44 192 EUR	46 289 EUR	—
Trade and other non-current receivables [abstract]
Trade and other non-current receivables	29 821 EUR	29 821 EUR	—
Trade and other current receivables [abstract]
Trade and other current receivables	18 420 EUR	21 814 EUR	—
Trade and other receivables [abstract]
Trade and other receivables	48 241 EUR	51 635 EUR	28 716 EUR
Categories of non-current financial assets [abstract]
Non-current financial assets	39 878 EUR	38 934 EUR	—
Categories of current financial assets [abstract]
Current financial assets	16 080 EUR	14 845 EUR	—
Cash and cash equivalents [abstract]
Cash and cash equivalents	103 756 EUR	136 792 EUR	202 887 EUR
Trade and other current payables [abstract]
Trade and other current payables	28 573 EUR	29 539 EUR	—
Trade and other payables [abstract]
Trade and other payables	28 573 EUR	29 519 EUR	36 047 EUR
Categories of non-current financial liabilities [abstract]
Non-current financial liabilities	13 503 EUR	16 945 EUR	—
Categories of current financial liabilities [abstract]
Current financial liabilities	30 748 EUR	2 142 EUR	—
Issued capital [abstract]
Issued capital	3 978 EUR	3 950 EUR	—
Net assets (liabilities) [abstract]
Assets	267 496 EUR	307 423 EUR	—
Net current assets (liabilities) [abstract]
Current assets	138 256 EUR	173 451 EUR	—
Current liabilities	79 886 EUR	45 488 EUR	—
Assets less current liabilities [abstract]